Skip to content

The effect of beta-caryophyllin on food addiction of women

The effect of beta-caryophyllin supplementation on neuropeptides affecting brain reward axis, mental health, eating behaviour, appetite and body composition in obese women with food addiction

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200914048712N1
Enrollment
84
Registered
2020-09-15
Start date
2020-12-21
Completion date
Unknown
Last updated
2020-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

food addiction. Overweight and obesity

Interventions

Intervention 1: Intervention group: Intervention with a dose of 100 mg soft gel beta-caryophylline per day for 2 months, 1 orally daily. The manufacturer is still unknown. Intervention 2: Control grou

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Body mass index between 30 to 99.99 kg/m2 confirmation of food addiction using the relevant questionnaire being in the age range of 18-50 years

Exclusion criteria

Exclusion criteria: Reluctance to continue collaborating with the study Having a weight loss diet in the last two months Menopause Continuous use (more than once a week) of vitamin and mineral supplements in the past month Pregnancy and lactation Consumption of alcohol, cigarettes (more than 3 cigarettes per day for the past 6 months), tobacco or drugs Use of weight loss and appetite suppressants Physical activity started from more than last three weeks History of neurological diseases or use of psychiatric drugs

Design outcomes

Primary

MeasureTime frame
Food addiction. Timepoint: at the baseline and end of study. Method of measurement: Yale Food Addiction Scale (YFAS).

Secondary

MeasureTime frame
Plasma oxytocin. Timepoint: Before and after the study. Method of measurement: ELISA.;Plasma neuropeptide Y. Timepoint: Before and after the study. Method of measurement: ELISA.;Orexin. Timepoint: Before and after the study. Method of measurement: ELISA.;Mental health. Timepoint: Beginning and end of the study. Method of measurement: Stress-Anxiety-Depression Questionnaire (DASS-21).;Body composition. Timepoint: At the beginning and end of the study. Method of measurement: body composition analyzer.;Appetite. Timepoint: At the beginning and end of the study. Method of measurement: Appetite questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Hassan Javanbakht

Tehran University of Medical Sciences

mhjavan2001@yahoo.com+98 21 4293 3333

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 17, 2026